SynGAP Research Fund
Palo Alto, Californiacuresyngap1.org
Overview
A 501(c)(3) public charity and family-led organization dedicated to improving the quality of life for SYNGAP1 patients. It is the largest non-governmental funder of SYNGAP1 research, awarding grants to researchers and clinicians to accelerate the development of treatments, therapies, and support systems for SYNGAP1-related disorders.
Portfolio Companies
5
Website
curesyngap1.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CAMP4 | Sep 2025 | Private Placement | Co-investor |
| Nospharma | Jul 2025 | Grant | Co-investor |
| Minovacca | Jan 2025 | Grant | Co-investor |
| 4M Therapeutics | Nov 2024 | Grant | Co-investor |
| Axonis Therapeutics | Sep 2024 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?